Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
Brain lesions differentiated by proton magnetic resonance spectroscopic imaging
April 11th, 2006
Nonneoplastic lesions and brain tumors were differentiated in children by proton magnetic resonance spectroscopic imaging (MRSI). According to a recent report, researchers in the United States conducted a study "to investigate whether in vivo proton MRSI can differentiate between: 1) tumors and nonneoplastic brain lesions, and 2) high- and low-grade tumors in children. Thirty-two children (20 males and 12 females, mean age=10.5 years) with primary brain lesions were evaluated retrospectively. Nineteen patients had a neuropathologically confirmed brain tumor, and 13 patients had a benign lesion." "Multislice proton MRSI was performed at TE=280 msec....
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
